However, novel biomarkers for bacterial or fungal sepsis, such as procalcitonin or adrenomedullin have shown promising sensitivity and specificity in identifying infection, but, to our knowledge, have not been studied specifically in the context of CRS, yet [91,92]. This evidence concerns the gene ADM and congenital rubella syndrome.